UNITED STATES | INTERNATIONAL
badge
INDICATIONS FOR USE: The TriVascular Ovation Abdominal Stent Graft System is indicated for use in subjects diagnosed with an aneurysm in the abdominal aorta with small aortic diameters and access vessels of less than 7 mm in diameter, having vascular morphology suitable for endovascular repair, including: adequate iliac/femoral access compatible with vascular access techniques, devices, and/or accessories; a non-aneurysmal proximal aortic neck with a length of at least 7 mm proximal to the aneurysm, with an inner wall diameter of no less than 15.5 mm and no greater than 17.4 mm, and with an aortic angle of d 60 degrees if proximal neck is > 10 mm and < 45 degrees if proximal neck is < 10 mm; adequate distal iliac landing zone with a length of at least 10 mm, with an inner wall diameter of no less than 8 mm and no greater than 17 mm.

CONTRAINDICATIONS: The TriVascular Ovation Abdominal Stent Graft System is contraindicated indicated for use in patients who have a condition that threatens to infect the graft and patients with sensitivities or allergies to the device materials. Also consider the information in Section 4 Warnings and Precautions of the systems Instructions for Use.

Refer to Instructions for Use at TriVascular.com for more information concerning Indications, Contraindications, Warnings and Precautions, and Adverse Events.

CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.

HUMANITARIAN DEVICE Authorized by Federal law for use in the treatment of abdominal aortic aneurysms. The effectiveness of this device for this use has not been demonstrated.

Upcoming Events

Charing Cross Interventional Symposium
London, UK
On 14 Apr 2012
www.cxvascular.com/cxsymposium
00.00

Vascular Annual Meeting
Washington, D.C.
07 Jun 2012-09 Jun 2012
www.vascularweb.org


Aug 2011: Manchester Evening News: - New Procedure Treats Aortic Aneurysms Without Major Surgery [Read Article]  

PRESS RELEASES

11 Apr 2012: Christopher G. Chavez Joins TriVascular, Inc. as Chairman, CEO and President [Download PDF]
02 Nov 2011:TriVascular, Inc. Receives U.S. Humanitarian Device Exemption Approval for the OvationTM Abdominal Stent Graft System [Download PDF]
02 Nov 2011:FDA approves system to repair abdominal aneurysms in people with small arteries [Read Article]
03 Aug 2011: TriVascular, Inc. Completes Enrollment of U.S. Pivotal Study and Initiates U.S. Continued Access Trial for the Ovation™ Abdominal Stent Graft System  [Download PDF]
23 Jul 2011: First Patients Treated in TriVascular’s OVATION Post Market Registry [Download PDF]
09 Apr 2011: TriVascular, Inc. Initiates the OVATION Post-Market Registry in Europe [Download PDF]
23 Mar 2011: TriVascular, Inc. Completes Enrollment of U.S. Pivotal Study of the Ovation™ Stent Graft System [Download PDF]
19 Jan 2011: Ovation Abdominal Stent Graft System Launched at The Leipzig Interventional Course [Download PDF]
17 Sept 2010: CE Mark Approval for Ovation Abdominal Stent Graft System [Download PDF]
12 Jul 2010: Series C Financing [Download PDF]
03 May 2010: First U.S. Pivotal Study Patient Enrolled [Download PDF]
22 Mar 2010: CE Mark Trial [Download PDF]
07 Dec 2009: First Human Use [Download PDF]
16 Nov 2009: Series B Financing [Download PDF]

MEDIA COVERAGE

Aug 2011: Manchester Evening News: - New Procedure Treats Aortic Aneurysms Without Major Surgery [Read Article]  
May 2010: Press Democrat:  - "Back on Track" [Read Article]
Apr 2010: In Vivo:  - "TriVascular's Sequel Could Be A Blockbuster" [Download PDF]